Please enable JavaScript to continue using this application.

Compare $DMRA vs $INBX | Chartloom

Compare

$DMRA vs $INBX

Damora Therapeutics Inc · Inhibrx Biosciences Inc

DMRA

Damora Therapeutics Inc

INBX

Inhibrx Biosciences Inc

Compare $DMRA vs $INBX

Comparing Damora Therapeutics Inc and Inhibrx Biosciences Inc

DMRADamora Therapeutics Inc

INBXInhibrx Biosciences Inc

DMRADamora Therapeutics Inc

Market cap

$1.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.4%

52W performance

-17.4%

FCF yield

-3.4%

INBXInhibrx Biosciences Inc

Market cap

$1.39B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

26.6%

52W performance

182.7%

FCF yield

-9.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DMRA

INBX

Detailed metrics comparison

DMRA

Damora Therapeutics Inc

INBX

Inhibrx Biosciences Inc

Market Cap

DMRA$1.30B

INBX$1.39B

Enterprise Value

DMRA$757M

INBX$1.44B

Price

DMRA$21.08

INBX$95.01

P/E Ratio

DMRAN/A

INBXN/A

P/S Ratio

DMRA0.00x

INBX1,019.62x

EV/Sales

DMRA0.00x

INBX1,050.29x

EV/EBITDA

DMRA0.00x

INBX0.85x

P/B Ratio

DMRA2.47x

INBX178.59x

P/FCF Ratio

DMRAN/A

INBXN/A

EV/FCF

DMRA-17.00x

INBX-10.89x

PEG Ratio

DMRAN/A

INBXN/A

Forward P/E (NTM)

DMRAN/A

INBXN/A

Forward P/S (NTM)

DMRAN/A

INBXN/A

Revenue (TTM)

DMRA$0

INBX$0

Revenue Growth (YoY)

DMRAN/A

INBX-100.0%

Forward Rev Growth

DMRA346.9%

INBX282.8%

Gross Margin (TTM)

DMRA0.0%

INBX0.0%

Operating Margin (TTM)

DMRA0.0%

INBX0.0%

EBITDA Margin (TTM)

DMRA0.0%

INBX0.0%

Net Margin (TTM)

DMRA0.0%

INBX0.0%

FCF Margin (TTM)

DMRAN/A

INBXN/A

Net Income (TTM)

DMRA$-265M

INBX$-138M

FCF (TTM)

DMRA$-45M

INBX$-132M

EPS (TTM)

DMRA-$4.34

INBX-$8.82

ROE (TTM)

DMRA-8306.0%

INBX-26956.0%

ROA (TTM)

DMRA-7849.0%

INBX-8348.0%

ROIC (TTM)

DMRA-8306.0%

INBX-9241.0%

Cash

DMRA$541M

INBX$133M

Debt

DMRA$0

INBX$176M

Net Cash/Debt

DMRA$541M

INBX$-43M

Current Ratio (TTM)

DMRA19.73x

INBX5.07x

Quick Ratio (TTM)

DMRA19.70x

INBX4.76x

Debt/Equity (TTM)

DMRA0.00x

INBX12.58x

Debt/Assets (TTM)

DMRA0.0%

INBX0.0%

Interest Coverage (TTM)

DMRAN/A

INBXN/A

Net Debt/EBITDA (TTM)

DMRA0.00x

INBX0.00x

Beta

DMRA-4.05

INBX3.17

52W Performance

DMRA-17.4%

INBX182.7%

YTD Performance

DMRA-17.4%

INBX26.6%

% from 52W High

DMRA-39.6%

INBX-38.8%

% from 52W Low

DMRA27.8%

INBX237.4%

Asset Turnover (TTM)

DMRA0.00x

INBX0.01x

FCF Yield (TTM)

DMRA-3.4%

INBX-9.5%

Earnings Yield (TTM)

DMRA-20.4%

INBX-9.9%

Dividend Yield (TTM)

DMRAN/A

INBXN/A

Rule of 40

DMRA0.0

INBX-100.0

EV/GP/RG

DMRAN/A

INBXN/A

Ticker research

View DMRA research View INBX research

Metric	DMRA Damora Therapeutics Inc	INBX Inhibrx Biosciences Inc
Market & Valuation
Market Cap	$1.30B	$1.39B
Enterprise Value	$757M	$1.44B
Price	$21.08	$95.01
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,019.62x
EV/Sales	0.00x	1,050.29x
EV/EBITDA	0.00x	0.85x
P/B Ratio	2.47x	178.59x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.00x	-10.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	346.9%	282.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-265M	$-138M
FCF (TTM)	$-45M	$-132M
EPS (TTM)	-$4.34	-$8.82
ROE (TTM)	-8306.0%	-26956.0%
ROA (TTM)	-7849.0%	-8348.0%
ROIC (TTM)	-8306.0%	-9241.0%
Financial Health
Cash	$541M	$133M
Debt	$0	$176M
Net Cash/Debt	$541M	$-43M
Current Ratio (TTM)	19.73x	5.07x
Quick Ratio (TTM)	19.70x	4.76x
Debt/Equity (TTM)	0.00x	12.58x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-4.05	3.17
52W Performance	-17.4%	182.7%
YTD Performance	-17.4%	26.6%
% from 52W High	-39.6%	-38.8%
% from 52W Low	27.8%	237.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-3.4%	-9.5%
Earnings Yield (TTM)	-20.4%	-9.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View DMRA research	View INBX research

Valuation

P/S Ratio

DMRA

0.00x

INBX

1,019.62x

EV/FCF

DMRA

-17.00x

INBX

-10.89x

Growth & revenue

Revenue Growth TTM

INBX

-100.0%

Forward Revenue Growth

DMRA

346.9%

INBX

282.8%

Profitability & performance

Gross Margin

DMRA

0.0%

INBX

0.0%

ROE

DMRA

-8306.0%

INBX

-26956.0%

FCF Yield %

DMRA

-3.4%

INBX

-9.5%

52-Week Performance

INBX

182.7%

DMRA

-17.4%

Detailed metrics comparison

DMRA

Damora Therapeutics Inc

INBX

Inhibrx Biosciences Inc

Market Cap

DMRA$1.30B

INBX$1.39B

Enterprise Value

DMRA$757M

INBX$1.44B

Price

DMRA$21.08

INBX$95.01

P/E Ratio

DMRAN/A

INBXN/A

P/S Ratio

DMRA0.00x

INBX1,019.62x

EV/Sales

DMRA0.00x

INBX1,050.29x

EV/EBITDA

DMRA0.00x

INBX0.85x

P/B Ratio

DMRA2.47x

INBX178.59x

P/FCF Ratio

DMRAN/A

INBXN/A

EV/FCF

DMRA-17.00x

INBX-10.89x

PEG Ratio

DMRAN/A

INBXN/A

Forward P/E (NTM)

DMRAN/A

INBXN/A

Forward P/S (NTM)

DMRAN/A

INBXN/A

Revenue (TTM)

DMRA$0

INBX$0

Revenue Growth (YoY)

DMRAN/A

INBX-100.0%

Forward Rev Growth

DMRA346.9%

INBX282.8%

Gross Margin (TTM)

DMRA0.0%

INBX0.0%

Operating Margin (TTM)

DMRA0.0%

INBX0.0%

EBITDA Margin (TTM)

DMRA0.0%

INBX0.0%

Net Margin (TTM)

DMRA0.0%

INBX0.0%

FCF Margin (TTM)

DMRAN/A

INBXN/A

Net Income (TTM)

DMRA$-265M

INBX$-138M

FCF (TTM)

DMRA$-45M

INBX$-132M

EPS (TTM)

DMRA-$4.34

INBX-$8.82

ROE (TTM)

DMRA-8306.0%

INBX-26956.0%

ROA (TTM)

DMRA-7849.0%

INBX-8348.0%

ROIC (TTM)

DMRA-8306.0%

INBX-9241.0%

Cash

DMRA$541M

INBX$133M

Debt

DMRA$0

INBX$176M

Net Cash/Debt

DMRA$541M

INBX$-43M

Current Ratio (TTM)

DMRA19.73x

INBX5.07x

Quick Ratio (TTM)

DMRA19.70x

INBX4.76x

Debt/Equity (TTM)

DMRA0.00x

INBX12.58x

Debt/Assets (TTM)

DMRA0.0%

INBX0.0%

Interest Coverage (TTM)

DMRAN/A

INBXN/A

Net Debt/EBITDA (TTM)

DMRA0.00x

INBX0.00x

Beta

DMRA-4.05

INBX3.17

52W Performance

DMRA-17.4%

INBX182.7%

YTD Performance

DMRA-17.4%

INBX26.6%

% from 52W High

DMRA-39.6%

INBX-38.8%

% from 52W Low

DMRA27.8%

INBX237.4%

Asset Turnover (TTM)

DMRA0.00x

INBX0.01x

FCF Yield (TTM)

DMRA-3.4%

INBX-9.5%

Earnings Yield (TTM)

DMRA-20.4%

INBX-9.9%

Dividend Yield (TTM)

DMRAN/A

INBXN/A

Rule of 40

DMRA0.0

INBX-100.0

EV/GP/RG

DMRAN/A

INBXN/A

Ticker research

View DMRA research View INBX research

Metric	DMRA Damora Therapeutics Inc	INBX Inhibrx Biosciences Inc
Market & Valuation
Market Cap	$1.30B	$1.39B
Enterprise Value	$757M	$1.44B
Price	$21.08	$95.01
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,019.62x
EV/Sales	0.00x	1,050.29x
EV/EBITDA	0.00x	0.85x
P/B Ratio	2.47x	178.59x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.00x	-10.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	346.9%	282.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-265M	$-138M
FCF (TTM)	$-45M	$-132M
EPS (TTM)	-$4.34	-$8.82
ROE (TTM)	-8306.0%	-26956.0%
ROA (TTM)	-7849.0%	-8348.0%
ROIC (TTM)	-8306.0%	-9241.0%
Financial Health
Cash	$541M	$133M
Debt	$0	$176M
Net Cash/Debt	$541M	$-43M
Current Ratio (TTM)	19.73x	5.07x
Quick Ratio (TTM)	19.70x	4.76x
Debt/Equity (TTM)	0.00x	12.58x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-4.05	3.17
52W Performance	-17.4%	182.7%
YTD Performance	-17.4%	26.6%
% from 52W High	-39.6%	-38.8%
% from 52W Low	27.8%	237.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-3.4%	-9.5%
Earnings Yield (TTM)	-20.4%	-9.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View DMRA research	View INBX research